Summarised: top 100 antibodies, proteins, lipids, biochemicals, and cell lines


Min Read

In this blog:

  • What were the key takeaways from each top 100 product dataset?
  • What trends did we see across all reagent types analysed?
  • What data analysis would you like to see from us?

By examining the most cited products in different reagent markets, we are able to glean unique insights into leading research, suppliers and reagents. 

This year, our top 100 blog series uncovered interesting data across five reagent types. This data was extracted from our complete database which covers over six million citations and twelve million products.

Today, we provide you with a rundown of the key takeaways from each blog and sample dataset. So, what did we discover about the top 100 antibodies, proteins, lipids, biochemicals and cell lines of the past year?

An overview infographic of key takeaways from the top 100 product blog series
An overview infographic of key takeaways from the top 100 product blog series

Key takeaways from each top 100 product blog

Top 100 antibodies – Analysing our top 100 antibody data for 2021, we discovered the leading suppliers (counting most products in the top 100 list) to be Cell Signaling Technology, Abcam, ThermoFisher, MilliporeSigma and Santa Cruz Biotechnology. Cell Signaling Technology dominated the dataset with over a third of the research antibody products and the most cited product of the year; anti rabbit igg, hrp linked antibody.

Download the antibody data from the blog

Top 100 proteins – For the top 100 proteins of 2021, we found that more companies featured in the dataset than in previous years. MilliporeSigma continues to dominate with nearly half of the top 100 proteins, and New England Biolabs made gains within the top 10. Two SARS-CoV-2 proteins also entered the dataset for the first time. 

Download the protein data from the blog

Top 100 cell lines – When we delved into the top 100 cell lines of 2021, we found that the not-for-profit ATCC dominated, with 97% of the top 100 cell lines. HEK293T cell lines remain the most highly cited, with VERO and HeLa cell lines also proving popular amongst researchers. We discovered that human derived cell lines made up 66% of the top 100 cell lines.  

Download the cell lines data from the blog

Top 100 lipids – For the top 100 lipids of 2021, a segment of the biochemicals dataset, we noted a new supplier named Lipoid entered the dataset for the first time with three products. MilliporeSigma held a significant 89 of the top 100 lipids, which included all of the top 10 products.

Download the lipid data from the blog

Top 100 biochemicals – Our analysis of the top 100 biochemicals in 2021 revealed that ThermoFisher supplied half of the top 100 most cited biochemicals, with MilliporeSigma closely following behind. We noted an increase in the number of cell culture products in the dataset as it has broadened over the past year.  

Download the biochemicals data from the blog

What trends did we notice across these datasets?

Taking a step back and looking at the data across all five reagent types analysed, we found some commonalities, including: 

  • Leading suppliers and new suppliers in the datasets
  • Changes in well cited products
  • Success for more niche suppliers

Firstly, we noted that across all of the datasets there was a dominant leader who supplied a significant proportion of the most highly cited products. 

However, we also saw new suppliers entering many of the top 100 datasets. This goes to show that these reagent markets are not remaining static, and up and coming players continue to see growing popularity with their products.

We found that ThermoFisher and MilliporeSigma featured in four of the five top 100 product datasets we generated for 2021, demonstrating a significant coverage of well cited products for these companies. Abcam also held products in two of the top 100 lists.

We also observed instances of some more specialist suppliers seeing success in our top 100 analysis. Examples include the lipid specialist Lipoid in the top 100 lipid dataset, and enzyme expert New England Biolabs in the protein dataset. 

Over the past year we have been working hard to continue expanding and improving our datasets. By broadening our data, we have seen the types of products in the top 100 lists changing for some of the reagent types. For example, we saw a greater proportion of cell culture products in our top 100 biochemicals dataset.

We also noted a number of new products entering the top 100 list for the first time, such as SARS-CoV-2 proteins, as well as products seeing increasing popularity amongst researchers, such as VERO cell lines. VERO cell lines are derived from the kidney epithelium of the African Green Monkey and commonly used in vaccine development. 

Final thoughts

Looking into our top 100 lists each year affords us a great opportunity to reflect back on how CiteAb data has grown, and how reagent markets are evolving. 

This year, we started to incorporate pre-prints and included Springer Nature and Wiley closed access journals into our database, helping to further improve the insights we can give into these reagent markets.

On a related note, we were excited to launch our new market insights package which includes data on top products, expanding on the insights we have covered in these blogs.

The market insights package includes four off the shelf reports each year, which also cover companies, countries and research areas. We have now launched this product for reagent types covered in our top 100 series. 

All that’s now left to say is thank you for reading our top 100 product blogs! We hope you found the series as interesting and informative as it was for us in producing it. 

We would love to hear from you on what reagent types you would like to see us focus on in our blogs next year. Is there a market you want to learn more about? Do reach out and let us know.

  • Rhys and the CiteAb team
About the author

Join thousands of people who already enjoy the CiteAb newsletter

To keep up to date with the latest developments to our search engine, news from our life science market data analysis and improvements to our citation provision.